(Q45970750)

English

Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

type 2 diabetes

0 references

Rossella Menghini

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Viviana Casagrande

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Massimo Federici

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

L Uccioli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

E Vainieri

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C Pecchioli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R Stoehr

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Cardellini

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

O Porzio

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Rizza

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Acta Diabetologica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

907-910

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

https://scigraph.springernature.com/pub.10.1007/s00592-013-0478-6

0 references

Management of diabetic foot problems

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Post-prandial glucose and diabetic complications: systematic review of observational studies

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Effects of high glucose and thiamine on the balance between matrix metalloproteinases and their tissue inhibitors in vascular cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

The role of ADAM17 in metabolic inflammation.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Mechanisms involved in the development and healing of diabetic foot ulceration

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0478-6

21 January 2018

Identifiers

10.1007/S00592-013-0478-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23636268%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45970750&oldid=1188771781"